These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10710069)

  • 1. The role of telomerase activity in hepatocellular carcinoma.
    Shimada M; Hasegawa H; Gion T; Utsunomiya T; Shirabe K; Takenaka K; Otsuka T; Maehara Y; Sugimachi K
    Am J Gastroenterol; 2000 Mar; 95(3):748-52. PubMed ID: 10710069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
    Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm.
    Yamashita Y; Tsuijita E; Takeishi K; Fujiwara M; Kira S; Mori M; Aishima S; Taketomi A; Shirabe K; Ishida T; Maehara Y
    Ann Surg Oncol; 2012 Jun; 19(6):2027-34. PubMed ID: 22203184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of des-gamma-carboxyprothrombin expression in hepatocellular carcinoma.
    Harino Y; Fujii M; Imura S; Morine Y; Ikemoto T; Soejima Y; Shimada M
    Hepatogastroenterology; 2008; 55(85):1385-9. PubMed ID: 18795695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of patients with hepatocellular carcinoma of multicentric origin.
    Okusaka T; Okada S; Nose H; Ishii H; Nakasuka H; Nakayama H; Nagahama H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(10):919-25. PubMed ID: 8884314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
    Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
    Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.
    Kiriyama S; Uchiyama K; Ueno M; Ozawa S; Hayami S; Tani M; Yamaue H
    Ann Surg; 2011 Dec; 254(6):984-91. PubMed ID: 21606837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
    Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
    J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
    Imamura H; Matsuyama Y; Miyagawa Y; Ishida K; Shimada R; Miyagawa S; Makuuchi M; Kawasaki S
    Br J Surg; 1999 Aug; 86(8):1032-8. PubMed ID: 10460639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.
    Sasaki A; Kai S; Iwashita Y; Hirano S; Ohta M; Kitano S
    Cancer; 2005 Jan; 103(2):299-306. PubMed ID: 15578688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.